When, where, and how to target vascular inflammation in the post-CANTOS era?
Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
Association Between Depressive Symptoms and Incident Cardiovascular Diseases
MINOCA: a heterogenous group of conditions associated with myocardial damage
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis